Skip to main content
TXG logo

TXG · 10x Genomics, Inc. · Analyst Estimates

Track TXG — free
$93.50 +4.74 (+5.34%) At close · Oct 2
Market Cap
$11.17B
Shares
130.29M
Volume · Oct 2 3.15M Avg daily vol (3M) 3.04M

Analyst Estimates

Compare analyst forecasts for 10x Genomics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-03 01:43 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.1
0.03667
0.18
—
0.105
0.0
0.105
0.0
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
614160000
620181340
627232000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
17
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.01
0.07667
0.17
—
0.20333
0.20667
0.20333
0.2
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
651841820
680928720
707500000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
17
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.04
-0.02
0.0
—
-0.01667
-0.03667
-0.01667
-0.03667
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
0
0
2
2
Revenue
USD
Publication date not stated
146300000
147735240
152200000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
16
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.06
-0.005
0.05
—
-0.00333
-0.01
-0.00333
-0.01
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
1
1
1
1
Revenue
USD
Publication date not stated
164650000
171172710
177203000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
16
— — — — — — — —
Key facts CIK 1770787 CUSIP 88025U109 13F (30d) 12 filings 10 filers Visit website Investor relations